Navigation Links
Albany New York Chocoholic, Adam Green, Accredits Xocai's "Change Your Chocolate" Success to Demand for Raw Acai Berry in Tokyo Japan and New Taipei Taiwan
Date:12/30/2013

f cacao, açaí and blueberries, called XoVita™. The Xovita ingredient combination is exclusive to Xoçai. Nevada-based MXI-Corp is a privately held company. Xoçai's nine chocolate products have the highest ORAC (antioxidant-measuring test) and flavonoid rich products available on the market. The Brooks family, owners and operators of MXI-Corp, have total combined chocolate sales of more than $1 billion. MXI Corp is now operating internationally in 41 countries. Adam@adamPaulGreen.com http://www.adampaulgreen.com/partnership 1-801-809-7766

Read the full story at http://www.prweb.com/releases/2013AlbanyNYAdamGreen/12ChangeYourChocolate/prweb11444948.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Justin Timberlake Tickets: Justin Timberlake Tickets in New York City, Albany, Uncasville, Baltimore, San Antonio, San Jose, Charlotte, San Jose, Kanata Go Onsale 11/18
2. Health Briefs TV Announces Air Dates for New York and Albany
3. Net Worth Commerce TV Announces Air Dates for Albany, New York
4. Oregon's Most Acclaimed Medical Marijuana "Canna Kitchen" Whips Up Smokeless Remedies for Albany OMMP Patients
5. Health Briefs TV Announces Air Dates for Albany, NY
6. 2013 Top Rated Home Alarm System Providers in Albany, New York According to 6Webs.com
7. FDA Approves New “Gummy Bear” Breast Implants, But Albany Plastic Surgeon Urges Caution
8. The J. Rich Company Capitalizes on Tenants’ Office Market for Non-Profit Client, Albany Park Community Center
9. A2LA Accredits Forensic Drug Testing Laboratory
10. AIUM accredits first urological practice
11. Xocai's New Xe Product Provides An Incentive For Marketing Xocolate International Corporation (MXI Corp) Distributors To Launch Their Business To A Whole New Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... to prevent Ebola virus disease will begin next week ... (NIAID), part of the National Institutes of Health. , ... a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) and ... generate an immune system response in healthy adults. Testing ... Bethesda, Maryland. , The study is the first of ...
(Date:8/28/2014)... patients in the study who were on a class ... them as prescribed in the first six months. Patients ... hospitals around the UK involved in the study. , ... and Genomics at The University of Manchester, who led ... correctly, known as ,non-adherence, reduced their effectiveness and may ...
(Date:8/28/2014)... AmeriPride Services, a leading textile services and supply ... its new Customer Portal, an online resource that makes ... for customers. The industry-leading digital tool allows customers to ... company. , Features of the new customer portal include ... and pay bills online , View delivery ...
(Date:8/28/2014)... 2014 Clarity PSO , an ... as a federal Patient Safety Organization (PSO) for another ... Healthcare Research and Quality (AHRQ). Clarity PSO will continue ... services following the true intentions of the Patient Safety ... are proud and eager to continue our journey as ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Genetic ... available throughout the world, with large reference laboratories ... Since laboratories differ with regard to the genetic ... costs, payers may struggle to find the most ... To help clients sort through these differences, Hayes, ...
Breaking Medicine News(10 mins):Health News:NIH to Launch human safety study of Ebola vaccine candidate 2Health News:NIH to Launch human safety study of Ebola vaccine candidate 3Health News:NIH to Launch human safety study of Ebola vaccine candidate 4Health News:NIH to Launch human safety study of Ebola vaccine candidate 5Health News:Arthritis patients failing to take expensive medication, according to new research 2Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2
... , ANN ARBOR, Mich., Dec. 16 ... diversity, a finding that raises social justice questions that must be ... cell advances, according to a University of Michigan research team. , ... analyzed 47 embryonic stem cell lines, including most of the lines ...
... Dec. 16 HealthSciences Institute will sponsor a new ... who serve individuals at risk of, or affected by, ... other provider settings. , The collaborative will offer free, ... chronic disease prevention, management and care improvement. Each webinar ...
... seven that increase susceptibility to disease , WEDNESDAY, Dec. ... susceptibility to leprosy have been identified by scientists in ... than 10,000 DNA samples from leprosy patients and healthy ... role that the innate immune response plays in the ...
... Institute announce the first comprehensive analyses of cancer genomes. ... of cancer cells which are acquired during a person,s lifetime. ... reveal for the first time essentially all the mutations in ... one million deaths worldwide each year: almost all are associated ...
... on a malaria elimination study in Africa have become the ... phone records. The scientists analyzed more than 21 million ... where they go. A semi-autonomous region composed of two islands ... drastically reduced malaria in recent years. Its government commissioned the ...
... ... Care Products from Episencial Offers Planet-Friendly Organics, Solar-Powered Manufacturing and Sustainable Packaging at an ... ... green values now have an authentic, affordable choice in all natural skin care for ...
Cached Medicine News:Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Leprosy Genes Identified 2Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5
(Date:8/28/2014)... , Aug. 28, 2014  Sequent Medical, ... enrollment in an Investigational Device Exemption ("IDE") pivotal ... the WEB™ Aneurysm Embolization System ("WEB"). Adam ... Department of Neurosurgery/Semmes-Murphey Clinic and Principal Investigator of ... the study, treating them with the WEB at ...
(Date:8/28/2014)... 28, 2014 GenSpera, Inc. (OTCQB: GNSZ), a ... cancer, announces the recent publication of the article "Targeting ... The recent article co-authored by Doan, et ... of GenSpera,s prodrug technology platform that is designed to ... plant Thapsia garganica ) directly to tumors. These ...
(Date:8/28/2014)... , Aug. 28, 2014 Synthetic ... novel anti-infective biologic and drug candidates targeting specific ... FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today ... of cGMP manufacturing of SYN-004, Synthetic Biologics, proprietary ... Clostridium difficile ( C. difficile ) infections. ...
Breaking Medicine Technology:Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 2Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 3GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 4Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5
... TRACON Pharmaceuticals, a biotechnology company that develops targeted ... Phase 1 clinical results from studies of TRC105 and ... at the American Society of Clinical Oncology annual meeting ... programs target unique pathways with the potential for broad ...
... Ascenta Therapeutics announced today that eleven presentations or publications ... pan-Bcl-2 inhibitor, in several major tumor types will be ... (ASCO) Annual Meeting, May 29-June 2, in Orlando, Florida. ... .(Logo: http://www.newscom.com/cgi-bin/prnh/20090227/PH75873LOGO ...
Cached Medicine Technology:TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009 2Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 2Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 3
... The Isoseeds I-125 are brachytherapy sources which ... of localized tumors, especially in the prostate. ... the conclusion of the therapeutic effect, i.e. ... are intended for single use. They are ...
... Four 64 mirrors for complete ... lens rotation. Directly hand held for ... or small holding ring. Small diameter ... gonioscopy without methylcellulose. Advanced technology, multi-layer ...
... Three mirrors of 64, ... small diameter contact surface for ... can be viewed through the ... Multi-layer polymer coating protects mirrors ...
West lacrimal cannula blunt tip with side port....
Medicine Products: